Advanced search
Publication Cover
Leukemia & Lymphoma Volume 57, 2016 - Issue 10
Submit an article Journal homepage
246
Views
1
CrossRef citations to date
0
Altmetric
Original Articles: Clinical

Phase I study of idarubicin dose escalation for remission induction therapy in acute myeloid leukemia

Mark Hong LeeDivision of Hematology-Oncology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, KoreaCorrespondence[email protected]
&
Sung-Yong KimDivision of Hematology-Oncology, Department of Internal Medicine, Konkuk University Medical Center, Seoul, Korea
Pages 2268-2274 | Received 29 Sep 2015, Accepted 28 Dec 2015, Published online: 15 Feb 2016
Supplemental material

ICMJE Forms for Disclosure of Potential Conflicts of Interest

Download Zip (2.2 MB)

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.